Patent details
EP2274978 Title: Methods for treatment of insulin-like growth factor-I(IGF-I) deficiency
Basic Information
- Publication number:
- EP2274978
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP100099761
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Methods for treatment of insulin-like growth factor-I(IGF-I) deficiency
- French Title of Invention:
- Méthodes de traitement de la déficience du facteur de croissance de type insuline 1 (IGF-1)
- German Title of Invention:
- Verfahren zur Behandlung von IGF-1 (insulin-like growth factor 1)-Mangel
- SPC Number:
Dates
- Filing date:
- 09/09/2004
- Grant date:
- 20/05/2015
- EP Publication Date:
- 20/05/2015
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 19/01/2011
- EP B1 Publication Date:
- 20/05/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 09/09/2015
- Expiration date:
- 09/09/2024
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 25/04/2015
- Name:
- Ipsen Biopharmaceuticals Inc.
- Address:
- 106 Allen Road, 3rd Floor, Basking Ridge, NJ 07920, United States (US)
Inventor
- Name:
- Clark Ross G.
- Address:
- New Zealand (NZ)
Priority
- Priority Number:
- 502579 P
- Priority Date:
- 12/09/2003
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A01N 37/18;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|